SNYR

Conviction 0HealthcareScan · Thu, Jun 25, 2026

SNYR$0.2075-0.67%

ResistanceSupportVol 14

Vol MA14 658.55K

Mar 26Apr 14May 1May 19Jun 8Jun 25

Synergy CHC Corp.MEDICINAL CHEMICALS & BOTANICAL PRODUCTSwww.synergychc.com ↗

Price0.2075

Change-0.67%

Gap-1.24%

Rel volume0.01×

Avg volume6.79M

Avg $ vol1.85M

SMA 200.2226

SMA 500.3013

SMA 2001.46

Price vs 50-31.14%

Price vs 200-85.81%

MA stackbearish

50/200 cross—

Supertrenddown · 0.2817

RSI (14)37

MACD hist0.01

MACD cross—

Stoch %K / %D34 / 33

ADX (14)19

+DI / −DI24 / 27

RSI divergence—

MACD divergence—

ATR %+14.25%

ADR %12.22%

52w high3.97

52w low0.1870

From 52w high-94.77%

Above 52w low+10.96%

New 52w highNo

SqueezeOff

Bollinger width49.93%

%B0.36

Donchian pos11.42%

Donchian high0.3820

Donchian low0.1850

AVWAP (52w high)0.4994

vs AVWAP high-58.45%

AVWAP (52w low)0.2090

vs AVWAP low-0.70%

OBV trendUp

Chaikin MF (20)-0.81

Today vs 20d0.01×

Avg vol (14d)658.55K

Avg vol (20d)6.79M

Avg $ vol (20d)1.85M

Market cap3.09M

RS 3m (vs SPY)-93.77%

RS 6m (vs SPY)-96.32%

RS line new highNo

Trend template0/8

Technical rank3.9

1 week-0.57%

1 month-21.73%

3 months-82.26%

6 months-89.08%

1 year-91.77%

YTD-88.96%

P/E-0.25

P/B-0.12

P/S0.11

P/FCF-1.14

EPS-1.27

Div yield37.97%

ROE48.58%

ROA-190.99%

Debt/Eq-1.14

Current0.93

EV/EBITDA-3.82

Gross margin69.16%

Net margin-42.04%

Rev growth-13.21%

EPS growth-680.77%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value31.82M

Revenue6.12M

Net income-2.57M

Gross profit3.97M

Free cash flow-2.71M

IndustryMEDICINAL CHEMICALS & BOTANICAL PRODUCTS

ExchangeNasdaq

Shares out15.08M

Employees28

ListedThu, Nov 7, 2013

Free float7.97M

Float %53.9%

Short interest3.4M

Days to cover0.3d

Short volume29.8%

Squeeze score41 / 100

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeD

Conviction0 / 100

Pattern quality—

Tech rank3.9 / 100

Group rank—

Status laneNo active setup

Setup direction—

Pattern family

Resistance0.4152

Support0.1878

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in SNYR

All disclosures →

No recent disclosed trades by Congress in SNYR. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in SNYR · 2 buys

Insider	Side	Shares	Value	Traded	Filed
Kaushal Nitin Director · Common Stock, par value $0.00001 per share · 2026-04-21	Grant	306.43K	$0	2026-04-21	2026-04-24
Thompson Teresa Brigid Director · Common Stock, par value $0.00001 per share · 2026-04-21	Grant	25.82K	$0	2026-04-21	2026-04-23

SEC filings

EDGAR filings in SNYR

EDGAR →

No recent SEC filings on file for SNYR.

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.